Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00166192 · ClinicalTrials.gov registry record · Phase 4
Treatment of Melasma With Jessner's Solution vs. Trichloroacetic Acid
A Phase 4 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 4
- Development phase
- 19
- Enrollment target
NCT00166192 is a Phase 4 study that has completed, run by Emory University. The registered enrollment target is 19 participants.
The verdict
NCT00166192, a Phase 4 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 19 participants
- Enrollment target
Study Summary
Melasma is an acquired discoloration of the skin characterized by brown patches. Chemical peels using agents such as Jessner's solution and trichloroacetic acid (TCA) are commonly used to treat melasma. A chemical peel involves applying the peeling agent to the skin for a short period. The skin will peel similar to a sunburn, and moisturizers are applied to the skin. Although both agents are well-accepted, there have been no good comparisons of the two agents. The purpose of this study is determine if there is a difference in the effectiveness of these two agents.
Interventions
- PROCEDURE Jessner's solution chemical peel
- PROCEDURE Trichloroacetic acid chemical peel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2008-01 |
| Est. Completion | 2013-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00166192
The ClinicalTrials.gov registry entry for NCT00166192 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Jessner's solution chemical peel is the first listed.
NCT00166192 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00166192 about?
NCT00166192 is a clinical study titled "Treatment of Melasma With Jessner's Solution vs. Trichloroacetic Acid". Melasma is an acquired discoloration of the skin characterized by brown patches. Chemical peels using agents such as Jessner's solution and trichloroacetic acid (TCA) are commonly used to treat melasma. A chemical peel involves applying the peeling agent to the skin for a short period. The skin will...
What is the current status of trial NCT00166192?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 19 participants. The study started on 2008-01. Estimated completion is 2013-11.
What interventions are being tested in trial NCT00166192?
The interventions under investigation include: Jessner's solution chemical peel (PROCEDURE), Trichloroacetic acid chemical peel (PROCEDURE).
Who is sponsoring clinical trial NCT00166192?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.